The "Signifying the Role of Endothelial to Mesenchymal Transition in Human Cardiovascular Disease" (EndMTracR) consortium ultimately aims to develop therapies that correct EndMT, as a new treatment for patients with cardiovascular diseases.
New Key Publication
We recently published a state-of-the-art review in the Journal of the American College of Cardiology:
Endothelial to Mesenchymal Transition in Cardiovascular Disease.
Jason Kovacic, Stefanie Drimmeler, Richard Harvey, Toren Finkel, Elena Aikawa, Guido Krenning, Andrew Baker
JACC Jan 2019, 73 (2) 190-209;
Lay and technical summaries of the EndMTracR research consortium and its aims.
A list of principal investigators and early career researchers involved in the EndMTracR consortium.
A list of publications from our consortium related to Endothelial to Mesenchymal Transition.
This article was published on